Tanios Bekaii‐Saab

Also affiliated with Mayo Clinic in Arizona, Mayo Clinic Hospital, Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

The Lancet(2023)10.1016/s0140-6736(23)01366-1

N/A

5.4DataRank · unranked

454 citations

Davide Melisi, Teresa Macarulla, Roberto Pazo-Cid, Sreenivasa R Chandana, Christelle de la Fouchardière +14 more

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040

N/A

3.5DataRank · unranked

127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0217

N/A

3.2DataRank · unranked

126 citations

Nataliya V. Uboha, Meredith S. Pelster, Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman +12 more

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma

JAMA Oncology(2020)10.1001/jamaoncol.2020.4930

N/A

0.795DataRank · unranked

200 citations

Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Daniel Almquist, Syeda A. Mina, Jehad Almasri +13 more

Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017

The Oncologist(2022)10.1093/oncolo/oyac150

N/A

0.668DataRank · unranked

85 citations

Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Smitha Sivaraman +6 more

First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.028

N/A

0.604DataRank · unranked

55 citations

Tanios Bekaii‐Saab, Patrick M. Boland, Farshid Dayyani, Teresa Macarulla, Kabir Mody +8 more

Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

European Journal of Cancer(2020)10.1016/j.ejca.2020.01.026

N/A

0.568DataRank · unranked

43 citations

Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai +9 more

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007586

N/A

0.546DataRank · unranked

37 citations

Gina R. Petroni, Todd W. Bauer, Matthew J. Reilley, Brian M. Wolpin, Chee‐Chee Stucky +14 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1444

N/A

0.505DataRank · unranked

28 citations

Patrick J. Lenehan, Victoire Cardot‐Ruffino, Andressa Dias Costa, Matthew H. G. Katz, Todd W. Bauer +16 more

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0.330DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

A phase II, multicenter, single-arm study of pemigatinib in patients with metastatic or unresectable colorectal cancer harboring FGFR alterations

The Oncologist(2025)10.1093/oncolo/oyaf069

N/A

0.232DataRank · unranked

3 citations

Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more

Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model

OncoImmunology(2020)10.1080/2162402x.2020.1818437

N/A

0DataRank · unranked

33 citations

Linlin Guo, Jay Overholser, Manuel L. Penichet, Tanios Bekaii‐Saab, Pravin T. P. Kaumaya

P-70 Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma: Multi-center single institution cohort experience

Annals of Oncology(2022)10.1016/j.annonc.2022.04.160

N/A

0DataRank · unranked

0 citations

Vanessa Wookey, Tyler Zemla, Q. Shi, Tanios Bekaii‐Saab, Nguyen H. Tran +2 more

Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease

British Journal of Cancer(2020)10.1038/s41416-020-1018-0

N/A

0DataRank · unranked

9 citations

Mohammad Y. Zaidi, Jennifer Yang, Michael K. Turgeon, Alyssa M. Krasinskas, Thomas A. Mace +14 more

Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

medRxiv(2021)10.1101/2021.11.01.21265773

N/A

0DataRank · unranked

0 citations

Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H. Ahn +25 more

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Digestive Diseases and Sciences(2021)10.1007/s10620-021-07303-9

N/A

0DataRank · unranked

12 citations

Thomas DeLeon, James M. Bogenberger, Rish K. Pai, Heidi Kosiorek, Jun Yin +26 more

Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer

The Oncologist(2021)10.1002/onco.13741

N/A

0DataRank · unranked

48 citations

Subir Goyal, Yoanna S Pumpalova, Mohamad Bassam Sonbol, Satya Das, Sigurdís Haraldsdóttir +10 more

Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3211

N/A

0DataRank · unranked

8 citations

Reetesh K. Pai, Heidi Kosiorek, Imon Banerjee, Ashlyn Pfeiffer, Catherine E. Hagen +16 more

Exploratory Analysis of PET and CA 19-9 Response in Pancreatic Ductal Adenocarcinoma Outcomes: A Secondary Analysis of a Prospective Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3047

N/A

0DataRank · unranked

0 citations

Ajit H. Goenka, William S. Harmsen, Mark J. Truty, Cornelius A. Thiels, Chee-Chee Stucky +13 more

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14215173

N/A

0DataRank · unranked

16 citations

Jennifer Gile, Mathias Earl Palmer, Tyler Zemla, Daniel H. Ahn, Tanios Bekaii‐Saab +4 more

CEACAM6 as a candidate biomarker for pelareorep sensitivity in pancreatic adenocarcinoma (PDAC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.746

N/A

0DataRank · unranked

0 citations

Jacob S. Yount, Jason J. David, Mindy Hoang, Colin W. Stets, Tanios Bekaii‐Saab +6 more